Cancer Currents: An NCI Cancer Research Blog

A blog featuring news and research updates from the National Cancer Institute.

An illustrated banner to represent NCI's Cancer Currents research news blog. The design features interconnected scenes: a patient receiving care, a researcher in a lab, a tumor model, a laptop and mobile device displaying research articles, fitness activity, a clinical setting, and a researcher giving a scientific presentation. The background showcases rolling hills and abstract buildings.

Making Sense of Key Cancer Reports
- By NCI Staff
- March 30, 2015
Several regularly released reports, including the Annual Report to the Nation—which is jointly released by NCI and several other organizations—provide information on important cancer trends in the United States.
A Week of Excitement and Hope: Communicating the Story of Cancer
- By Peter Garrett
- March 30, 2015
Peter Garrett, acting director of NCI's communications office, discusses the Annual Report to the Nation on the Status of Cancer and activities surrounding the broadcast of the documentary film, Cancer: The Emperor of All Maladies.
FDA Approves First Therapy for High-Risk Neuroblastoma
- By NCI Staff
- March 27, 2015
The FDA has approved dinutuximab as part of first-line therapy for children with high-risk neuroblastoma.
FDA Approves First Immunotherapy Treatment for Lung Cancer
- By NCI Staff
- March 24, 2015
The FDA has approved nivolumab to treat patients with advanced non-small cell lung cancer that has progressed during or after treatment with platinum-based chemotherapy.
The Exceptional Responders Initiative: Welcoming More Cases
- By NCI Staff
- March 24, 2015
The initiative is studying tissue, clinical, and genomic data from patients with cancer who have had dramatic and long-lasting responses to standard and experimental treatments that were not seen in similar patients who received the same treatment.
Who Will Respond to PD-1 Inhibition? Study Provides Clues
- By NCI Staff
- March 24, 2015
A new study shows that specific DNA changes in a tumor may help determine which patients are most likely to respond to treatment with PD-1 inhibitors
FDA Approves Panobinostat for Some Patients with Multiple Myeloma
- By NCI Staff
- March 19, 2015
The FDA granted accelerated approval of panobinostat for the treatment of multiple myeloma that has progressed after at least two prior standard therapies.
DNA "Minicircles" Could Improve Cancer Detection, Study Suggests
- By NCI Staff
- March 19, 2015
Injecting customized DNA “rings” into tumor-bearing mice caused the tumor cells to release a biomarker that can be detected with a simple blood test.
Smoking’s Disease Burden: Worse than Previously Thought?
- By NCI Staff
- March 16, 2015
According to a new study, smoking may be responsible for far more deaths each year than previously thought.
Treatment Helps Preserve Fertility for Some Women with Breast Cancer
- By NCI Staff
- March 12, 2015
In a large clinical trial, giving a hormone-suppressing drug helped some younger women with breast cancer get pregnant after completing cancer treatment.